Cases of monkeypox are suddenly popping up all around the world, and the U.S. is stocking up on vaccines – leading many to suspect that this could be the next major plandemic.
This month, the first confirmed case of the virus was allegedly found in Massachusetts.
The U.S. government then proceeded to buy 13 million Monkeypox vaccines from a company called Bavarian Nordic – a company which just so happened to receive $100 million in funding from Fauci’s NIAID.
The US health authorities have signed a deal for $119 million through the Biomedical Advanced Research and Development Authority (BARDA) – a government agency devoted to combating pandemics and bioterrorism.
The $119 million deal is one in a series of contract options which could ultimately reach a total value of $299 million if exercised. Initial deliveries for the shot won’t come until 2023, the company said, noting that the full 13 million doses are expected to be ready sometime between 2024 and 2025 should BARDA agree to extend the contract.
But the U.S. is not alone. Bavarian Nordic announced that it had also reached a deal with an “undisclosed European country” for the same dual-use smallpox vaccine – though offered under different branding – “in response to new cases of monkeypox.” The company did not elaborate on how many doses would be procured or provide an overall price tag for the contract.
Could this be the global elite’s latest plan to trap and control us?